Deprecated (16384): The ArrayAccess methods will be removed in 4.0.0.Use getParam(), getData() and getQuery() instead. - /home/brlfuser/public_html/src/Controller/ArtileDetailController.php, line: 150
 You can disable deprecation warnings by setting `Error.errorLevel` to `E_ALL & ~E_USER_DEPRECATED` in your config/app.php. [CORE/src/Core/functions.php, line 311]
Deprecated (16384): The ArrayAccess methods will be removed in 4.0.0.Use getParam(), getData() and getQuery() instead. - /home/brlfuser/public_html/src/Controller/ArtileDetailController.php, line: 151
 You can disable deprecation warnings by setting `Error.errorLevel` to `E_ALL & ~E_USER_DEPRECATED` in your config/app.php. [CORE/src/Core/functions.php, line 311]
Warning (512): Unable to emit headers. Headers sent in file=/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Debugger.php line=853 [CORE/src/Http/ResponseEmitter.php, line 48]
Warning (2): Cannot modify header information - headers already sent by (output started at /home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Debugger.php:853) [CORE/src/Http/ResponseEmitter.php, line 148]
Warning (2): Cannot modify header information - headers already sent by (output started at /home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Debugger.php:853) [CORE/src/Http/ResponseEmitter.php, line 181]
LATEST NEWS UPDATES | RTI Act not applicable to HPV vaccine project by Aarti Dhar

RTI Act not applicable to HPV vaccine project by Aarti Dhar

Share this article Share this article
published Published on Aug 9, 2010   modified Modified on Aug 9, 2010


‘Trade secret of third party' can't be disclosed: Drugs-Controller

Application seeks information on the basis of approval for import and marketing of vaccines

It seeks to know protocols for permission to an NGO and ICMR to conduct ‘demonstration project'

Information on the demonstration project and licensing of two vaccines to prevent cervical cancer has been exempted from public disclosure under Section 8 of the Right to Information Act, 2005.

This is the reply received in response to an RTI application, submitted to the Union Ministry of Health and Family Welfare, seeking information on the status and basis of approval granted to Merck Sharp and Dohme (MSD) Corp. and GlaxoSmithKline (GSK) to import, sell and market Gardasil and Cervarix in India, and the status, design and intent of the trials conducted by MSD and the Indian Council of Medical Research (ICMR).

It also sought information on the protocols adopted for granting permission to the Program for Appropriate Technology and Health (PATH), a non-governmental organisation, and the ICMR to conduct the ‘demonstration project.'

All RTI applications have evoked a stock reply from the office of the Drugs Controller-General of India: the requested information is a “trade secret and commercial confidence of the third party and exempted from disclosure under Section 8 (1) (d) of the RTI Act.”

The applications were filed by health activist Deepa Venkatachalam of Sama-Resource Group for Women and Health. The Union Ministry of Health and Family Welfare directed them to the Central Drugs Standard Control Organisation, which responded to the applications.

The ‘clinical trials' of Gardasil (of Merck) and Cervarix (of GSK) in Gujarat and Andhra Pradesh were suspended in April this year after allegations emerged of violations of ethical norms by PATH, which conducted the trials for MSD and GSK. Some girls suffered side-effects after being administered the vaccine.

To a query on the purpose of the demonstration project, the government said the aim was to demonstrate a suitable strategy for delivery of vaccine to girls aged 10-14; to raise community awareness of HPV (human papilloma virus) and cervical cancer and its prevention.Responding to another query whether the demonstration project was a clinical trial, and if so, which phase it was in, the government said it was “phase IV” of post-licensure observation study under the Drugs and Cosmetics Act. It said documents related to the project were exempted from public disclosure.

“We are not going into the ethics or efficacy of the vaccines but just sought information on the study design or the protocol of a demonstration project that sought to gain experience and build evidence for future introduction of HPV vaccine in the public health system. How can it be considered a trade secret,” asks Sarojini, another SAMA activist.


The Hindu, 9 August, 2010, http://www.hindu.com/2010/08/09/stories/2010080961521800.htm


Related Articles

 

Write Comments

Your email address will not be published. Required fields are marked *

*

Video Archives

Archives

share on Facebook
Twitter
RSS
Feedback
Read Later

Contact Form

Please enter security code
      Close